Search
for
Sort by
Research 631–660 of 1000+
- 51223 A novel human disease model of alopecia areata to evaluate benefit of the DHODH inhibitor farudodstat
- 90 Exploring the therapeutic potential of DHODH inhibitor farudodstat for alopecia areata treatment in a novel ex vivo model of human hair follicle immune privilege collapse
- LB1777 A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- Nitric Oxide Signal Transduction and Its Role in Skin Sensitization
- Dermatophytosis in Cats: Clinical Signs and Identification of Etiological Agent
- Alopecia Areata: An Overview of the Disease and its Genetic Basis: Review Article
- Tracing immune cells around biomaterials with spatial anchors during large-scale wound regeneration
- Canine and Feline Cutaneous Lymphocytosis: Reactive Process or Indolent Neoplastic Disease?
- Role of distinct fibroblast lineages and immune cells in dermal repair following UV radiation induced tissue damage
- Developing human fetal skin demonstrates a unique lymphocyte signature
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- 664 Understanding the pathogenesis of seborrhea-like dermatitis in the Mpzl3 knockout mice
- Hair Physiology (Hair Growth, Alopecia, Scalp Treatment, etc.)
- Alopecia Areata
- Summary of the Preceding Three Alopecia Areata Research Summits: What’s Past Is Prologue
- Cutaneous drug reactions
- 탈모 환자의 적외선 체열 진단상 안면부 체열 특성
- Alopecia areata
- New Synthesis of Finasteride
- Tinea Capitis in Infants
- Androgens inhibit phagocytosis by macrophages via the androgen receptor in vitro
- Pharmacologically altered Androgens, Brain Activation and Response Inhibition in a Stop-Signal Task in Male Heavy Drinkers
- The Hormonal Background of Hair Loss in Non-Scarring Alopecias
- Insights From Liquid Chromatography-Mass Spectrometry-Measured Androgens in Indian Women With Polycystic Ovary Syndrome
- COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role?
- Longitudinal clinical course in patients with 5α-reductase type 2 deficiency treated with testosterone and dihydrotestosterone during infancy and puberty
- Disorders of sex development (DSD) 46.XY due to type 2 5-α reductase deficiency in three siblings: Case report from a low-resource setting
- Sa1389: LESSONS FROM HEPATITIS C TREATMENT DURING THE COVID-19 PANDEMIC: DECREASED RESOURCE UTILIZATION LEADS TO SIMILAR EFFICACY IN BRITISH COLUMBIA, CANADA
- In response to the letter to the editor by Soha Ghanian et al. re our publication “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males”
- 104 Flibanserin Subset Analyses and the Androgenics of Hypoactive Sexual Desire Disorder